sk&f 106760 has been researched along with Coronary Thrombosis in 1 studies
*Coronary Thrombosis: Coagulation of blood in any of the CORONARY VESSELS. The presence of a blood clot (THROMBUS) often leads to MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boppana, V; Koster, PF; Miller-Stein, C; Nichols, AJ; Rhodes, GR; Samanen, JM; Valocik, RE; Vasko, JA | 1 |
1 other study(ies) available for sk&f 106760 and Coronary Thrombosis
| Article | Year |
|---|---|
The in vivo pharmacological profile of the novel glycoprotein IIb/IIIa antagonist, SK&F 106760.
Topics: Animals; Blood Platelets; Coronary Thrombosis; Dogs; Fibrin; Male; Peptides, Cyclic; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Streptokinase | 1994 |